Carvedilol ER 80 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26F1F47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,608
Award facts
- Contract value 100% obligated
- $11,607.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,607.53 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count packaging) on November 4, 2025, with completion anticipated by November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, continues to fulfill critical pharmaceutical procurement requirements for the Department of Defense and related federal health agencies through its comprehensive prime vendor agreement. The SPE2DX contract vehicle enables the company to deliver a broad spectrum of medications and medical supplies across multiple therapeutic domains to support military healthcare programs. This specific delivery order for Carvedilol, a beta-blocker medication commonly used in cardiovascular treatment, reflects the contractor's ongoing role in supplying essential pharmaceutical commodities to support federal medical supply chains serving active-duty personnel, veterans, and other eligible beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1F47?
SPE2DR26F1F47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F1F47 worth?
The government has obligated $11,608 on SPE2DR26F1F47.
Is contract SPE2DR26F1F47 an order under another contract?
Yes. SPE2DR26F1F47 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1F47 competed?
The extent of competition for SPE2DR26F1F47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award